
HeartBeam fell 76.7% from $1.54 to $0.36, behind the S&P 500's +11.2%. Its worst day was Nov 21 (−53.5%), and its low came Nov 16 at $0.36.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
HeartBeam shares fell 53.5%, while the S&P 500 rose 1.0%.
−53.5%, the year's worst day · S&P 500 +1.0%
Story events cover the past 12 months · Times ET
HeartBeam closed at its highest level of the year, 123.4% above where the year started.
+30.8% · S&P 500 −0.3%
EPS of $-0.14 missed the $-0.13 estimate on $0.00 revenue (est. $200,000.00).
−7.5% · S&P 500 −0.6%
HeartBeam shares fell 26.2%, while the S&P 500 rose 0.8%.
−26.2% · S&P 500 +0.8%
EPS of $-0.12 beat the $-0.14 estimate on $0.00 revenue (est. $139,800.00).
+3.0% · S&P 500 +0.8%
EPS of $-0.10 missed the $-0.09 estimate on $0.00 revenue (est. $76,000.00).
−15.3% · S&P 500 −0.2%
The designation recognizes the potential of HeartBeam’s 3D ECG technology, which captures the heart’s electrical signals from three non-coplanar dimensions, to enable physicians to evaluate signs of a possible heart
+50.5%, on 404M shares, the year's heaviest volume · S&P 500 +0.7%
HeartBeam shares rose 32.8%, while the S&P 500 rose 0.3%.
+32.8% · S&P 500 +0.3%
EPS of $-0.05 beat the $-0.09 estimate on $0.00 revenue (est. $68,000.00).
−2.0% · S&P 500 −0.4%
Where it ended: a close of $0.36 on Nov 16, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-0.06, revenue est. $216,000.00).
Nothing in the past 12 months.
All BEAT dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BEAT and SPY from Benzinga historical bars. Not investment advice.